Introduction
Occipital neuralgia is defined by the international headache society (IHS) as a unilateral or bilateral paroxysmal, shooting or stabbing pain in the posterior part of the scalp, in the distribution of the greater and lesser occipital nerves, sometimes accompanied by diminished sensation or dysaesthesia in the affected area and commonly associated with tenderness over the involved nerve(s) [1] . This pain usually originates in the suboccipital region and irradiates to the vertex.
There is no definitive data about the prevalence or incidence of occipital neuralgia, there is a Dutch study which reported a low incidence of 3.2 per 100,000 [2] . However this is the only study that exists to date and is thought to be an underdiagnosed entity due to the number of differential diagnosis that is possible.
Many etiologies of occipital neuralgia have been reported in the literature, however the most common one is of compressive origin either by trauma which causes subsequent fibrosis or by muscle contraction [3] .
There are currently various accepted treatment methods reported in the literature, ranging from medical treatment using neuropathic agents such as antiepileptic and/or antidepressant medications which is considered as the first line of treatment, local injections to the nerve using local anesthetics combined with steroids are also considered a treatment as well as a diagnostic test, lately nerve stimulation has been given much attention and even a systematic review and evidence-based guideline was published about this method concluding that it has a level III recommendation strength [4] .
Neurostimulation of the occipital nerve or occipital nerve stimulation is a relatively new technique which is made inserting subcutaneous electrodes in the C1-C2 region of the posterior cervical spine and passing current through them. It is believed that this results in activation of the C1-C3 cervical nerves afferents as well as the trigeminal afferents through the convergence that happens between these fibers. This is an alternate technique opposed to destructive surgery. If the patient does not want to continue the treatment, the device can be removed with a simple procedure [3] .
Neurolysis of the occipital nerve (with or without sectioning of the inferior oblique muscle), C2 gangliotomy, C2 ganglionectomy, C2 to C3 rhizotomy, C2 to C3 root decompression, and neurectomy were historically introduced for medically refractory patients [5] [6] [7] [8] [9] . But ultimately have lost its place in favor of nerve stimulation.
Our aim in this study is to report our experience and treatment algorithm with our modified neurectomy surgical technique which provides excellent results in pain control for patients who suffer occipital neuralgia and that can be considered as a safe alternative when neurostimulation and radiofrequency are not available.
Methods
We performed a retrospective chart review of all 26 subjects diagnosed with occipital neuralgia from January 2014 when our treatment algorithm started to be used in our institution and obtained an 18 subjects case series with follow ups of 6 months and more who underwent our treatment algorithm for Occipital neuralgia.
Patient selection
Starting in January 2014 all patients that were diagnosed with occipital neuralgia under the IHS classification comprising the next clinical features ( Table 1) were enrolled to our algorithm for occipital neuralgia treatment ( Fig. 1 ).
Treatment algorithm
After being diagnosed clinically as occipital neuralgia, all patients underwent the treatment algorithm, in which as a mean of confirmation of the neuralgia and as a treatment method they were offered a local injection with ropivacaine and dexamethasone, patients were required to sign an informed consent in order to obtain the injection, if they refused they were treated medically only with option to receive the injection if they ultimately decided to sign the consent. 26 patients were identified with occipital neuralgia, all patients signed the consent and underwent the local injection first and 22 underwent microsurgical decompression and neurectomy, however we reduced our case series to 18 due to incomplete follow-up in 4 cases.
All cases received evaluation using the Barrow Neurological Institute Pain Score (BNIPS) ( Table 2 ) in order to evaluate the pain frequency and control as well as the Visual Analogue Scale (VAS) to evaluate pain intensity and clinical evaluation of sensitivity in the C2 dermatome.
Local injection
Once the side and affected nerves were identified, we injected either 1 or 2 points (this depended on the number of nerves affected, if it was only the GON, LON or both) in accordance to the Vital and Becser [10] previously reported technique, we used for injection a combination of ropivacaine 7.5% and dexamethasone 8 mg titered at 1:1 ratio, for each point we injected 10 ml ( Fig. 2) .
After local injection patients were immediately discharged and came back for evaluation at 6 weeks, if the improvement on VAS and BNIPS was more than 50% then the patient was deemed as a good candidate for surgical decompression and neurectomy of the affected nerve and the surgery was offered, out of the 26 subjects, 22 accepted the surgical treatment immediately, the other 4 presented reduction in pain b 50% and entered the algorithm for reevaluation and medical treatment and are currently being followed.
Surgical procedure

Patient positioning
The subjects were placed in a prone position with the head resting on a horseshoe adapter for the Mayfield headrest with a 45 degree flexion of the neck to provide better exposure of the cervical spinous processes and the inion to locate the superficial landmarks, the thorax is I  No pain, no medications  II  Occasional pain, no medications required  III  Some pain, adequately controlled with medications  IV  Some pain, not adequately controlled with medications  V  Severe pain or no pain relief placed over two gel rolls and all of the pressure points are padded ( Fig. 3 ).
Incision planning and superficial landmarks
Incision was planned according to the affected side and nerves, if the neurectomy was going to be of the GON a linear 3 cm incision was made 3 cm from the midline at the level of the inion, extending 1.5 cm superior and 1.5 cm inferior. If the LON was the affected nerve then the incision would be made 5.5 cm from the midline, if both nerves were affected then the incision would be made at the midpoint of this two markings ( Fig. 4 ).
Microsurgical decompression and neurectomy
The incision was performed using an 11 blade and careful blunt dissection through the subcutaneous plane is made with Metzenbaum scissors approximately 1 cm to each side until the nerve is identified, for faster identification of the nerve we suggest using the occipital artery pulsations since in this portion of the nerve the artery is adjacent to it, then the nerve trajectory is followed while performing its decompression from the P2 portion at the exit point in the nuchal line to 3 cm distal to the exit point, the proximal end of the nerve is ligated using 2-0 chromic catgut to avoid formation of neuromas and the nerve is excised completely along with the fibrosis surrounding it and sent to pathology.
Closure
After decompression and neurectomy had been achieved, hemostasis was ensured with bipolar coagulation and a two-stage closure performed, closing the galea and subcutaneous tissue with interrupted inverted 2-0 vicryl, the superficial skin was closed using a subcutaneous continuous suture with 3-0 monocryl.
Post-surgery follow up
All patients remained hospitalized for 24 h after surgical decompression for pain evaluation. Subjects were evaluated using the VAS and BNIPS at the immediate postoperative time (24 h) as well as 3 and 6 months postoperatively, in some cases we also report the 12 and 18 month follow up evaluations. Sensitivity in the C2 area was also evaluated.
Statistical analysis
Median and standard deviations were used to describe the population of the study as well as the pathology. The Wilcoxon Signed-Rank test was performed to obtain the p value in the comparison of the BNIPS and VAS at the different times they were evaluated. All calculations were performed using IBM SPSS 24 for Mac.
Results
Population
Twenty-six patients fulfilled the criteria in the IHS classification for occipital neuralgia, and entered the algorithm, of these subjects, 22 were women (85%) and the mean age was of 53.9 years with an SD of 11.8 years (Table 3 ). The most common laterality of the pain was right in 18 cases (69%) and the involved nerves were the GON in 100% of cases and in 24% of cases there were two nerves involved, the LON in 20% and the third occipital nerve in 4%.
Ten subjects (38%) had the previous history of a whiplash injury in the neck in the past two years before their intervention.
Local injection
All 26 patients underwent local injection using the previously described method, of which at 4 weeks follow up 22 presented an improvement in subjective pain of more than 50% and according to the algorithm were offered the decompression and neurectomy, the other 4 subjects presented an improvement of b50% and were sent for reevaluation and started medical treatment. No complications were reported for this intervention.
Surgical decompression and neurectomy
Twenty-two cases underwent microsurgical decompression and neurectomy, of which 4 were excluded for analysis in this study due to the fact they do not have adequate follow-up notes, with no information of the Barrow Neurological Institute Pain Scale (BNIPS) and Visual Analogue Scale (VAS) ( Table 4 ).
In the 18 analyzed cases the surgical time had a mean of 70 min with a standard deviation (SD) of 21.62 min, the estimated blood loss was 56.1 ml with an SD of 54.7 ml.
The most common laterality of the pain was right in 12 cases (66%) and only in 5 cases (27%) two nerves were involved in the pain etiology in one case it was the third occipital nerve which was approached using the same incision as the one used for the GON and in the other four cases it was the LON which was approached using the incision described in (Fig. 4) , the results of the general characteristics of subjects who underwent the operation are summarized in Table 4 .
In the immediate postoperative evaluation which was performed during the hospitalization period which was the same for all subjects (24 h), we observed a clear diminish in both pain scales, in the BNIPS the reduction in pain was of 50% and in the VAS 62%. Using the Wilcoxon Signed-Rank Test we obtained the Z value for both scales in the preoperative and postoperative evaluation resulting statistically significant for p b 0.01 in both scales, this is summarized in Table 5 , all patients presented anesthesia in the C2 dermatome on the side of the surgery in this evaluation.
No complications from the surgery were reported and all patients were discharged at 24 h posterior to the operation.
Follow up
At 3 & 6 months follow up the benefits in term of pain control (BNIPS) and pain intensity (VAS) were still present, no increase in either frequency or intensity of pain was noted, there was a small reduction in the BNIPS scale and VAS as well but were not significantly different than in the postoperative evaluation. Out of the 18 cases, 10 have follow-ups up to 12 months and 7 to 18 months showing that the benefit in both scales is still present with no significant increase.
In terms of the sensitivity in the C2 dermatome, 10 subjects regained normal sensitivity at 3 months and 12 subjects at 6 months, only 6 subjects persisted with anesthesia at the end of this period.
Pathology
Pathology results for the 18 subjects were reported as perineural fibrosis and vascular congestion around the nerves.
Discussion
Even though prevalence and incidence in this pathology is not well known and there is only one report in the literature stating that the incidence is around 3.2/100,000/year 2 we found that in our population this incidence is much smaller, at 1.2/100,000/year which may result from the characteristics of our own population which is comprised only by the Mexican Oil Company workers and their family being most of our affiliates of young age, also most of our affiliates are male and as it is demonstrated in this case series this disease is more prevalent in females.
One of the main reasons to propose this type of surgery is that the other main options for treatment such as radiofrequency are not widely available in our country and the pain management using medications is not as effective due to the poor adherence to the drugs used to treat occipital neuralgia and the side effects that they produce, it has been noticed in other pathologies such as cancer than adherence to analgesic regimes is very poor and that this significantly damages the ability of an adequate pain control [11] .
The neurectomy technique we modified poses a small risk for complications and mortality, in our case series this was 0%, and the costeffectivenes of this potentially curative treatment is much greater than having subjects with occipital neuralgia receiving medications or continuous therapies of occipital nerve stimulation, it is widely known that the surgical options have substantial benefits in carefully selected pain patients [12] which is the main reason why we have a complex algorithm involving trial of the potential benefit before performing the surgery.
As it is known the main etiology for occipital neuralgia is the formation of fibrosis and muscle contraction in the area in which the nerve exits the fascia, in our case series 38% of the subjects had the past medical history of neck trauma which could have been the cause of fibrosis and muscle contraction in this area. In the remainder of subjects in Age, surgical time and EBL are given in mean and standard deviation. which fibrosis was always found without a history of neck trauma, other physical stressors in life might have been submitted small repetitive neck trauma.
Conclusion
Microsurgical decompression of the occipital nerves along with neurectomy is a safe and effective alternative to treat occipital neuralgia with satisfactory results.
We recommend the use of the infiltration diagnostic and therapeutic test to confirm the diagnosis of occipital neuralgia before proposing any type of surgical intervention for this pathology.
The sensitivity disturbances after neurectomy of the GON, LON or III ON are usually reversible within 6 months of neurectomy.
The Barrow Neurological Institute Pain Score is the best tool to categorize this type of patients due to the fact that it is designed for neuropathic pain.
